Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)

Inclusion Criteria: * \> 18 years old * Lipid Metabolic Disorder as Per ATP III who have not reached the goals and who are on statins for at least 4 weeks Or those who require LDL reductions Over 50% to reach the ATP III goals or who need statins in accordance their risk score Exclusion Criteria: * Pregnancy, Breast Feeding * Moderate/Sever Liver Disease: Child Score \> Or = To 7 * Fibrates Terminal Disease * Contraindications To Receive ezetimibe * Contraindications To Receive Statins * Mental Disability * Hypersensitivity To ezetimibe * On another Clinical Research Trial